Advertisement

Journal of General Internal Medicine

, Volume 11, Issue 12, pp 744–749 | Cite as

Does treatment withl-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?

  • Roman Jaeschke
  • Gordon Guyatt
  • Hertzel Gerstein
  • Christopher Patterson
  • William Molloy
  • Deborah Cook
  • Sandra Harper
  • Lauren Griffith
  • Ramona Carbotte
Original Articles

Abstract

OBJECTIVE: To determine if health-related quality of life (HRQL) in patients of middle age and older with elevated thyroid-stimulating hormone (TSH) and normal total thyroid hormone levels—subclinical hypothyroidism—improves withl-thyroxine replacement therapy.

DESIGN: Randomized, double-blind, placebo-controlled trial.

SETTING: Outpatient clinic.

PATIENTS: Thirty-seven patients with subclinical hypothyroidism, most with symptoms consistent with hypothyroidism, over 55 years of age.

INTERVEJVTIOJVS: Placebo or L-thyroxine replacement therapy to achieve normal TSH level.

MEASUREMENTS AND MAIN RESULTS: Disease-specific and general HRQL, cognitive function, bone mineral density, lipid levels. The mean daily dose of L-thyroxine replacement in the active group was 68±21 µg. TSH decreased by 8.6 mIU/L (95% confidence interval [CI] 4.1 to 13.1) and T4 increased by 27.9 nmol/L (95% CI 14.8 to 41.2). There was a statistically significant improvement in a composite psychometric memory score in treated versus control patients; all other outcomes showed similar findings in the two groups. Although confidence intervals for most measures did not exclude an important improvement in HRQL with thyroid replacement, no measure of symptoms or HRQL either showed clinically important trends in favor of treatment, or approached conventional levels of statistical significance.

CONCLUSIONS: In middle-aged and older patients with elevated TSH and normal T4, it may not be harmful to follow biochemical and clinical status even in the presence of nonspecific symptoms potentially associated with hypothyroidism.

Key words

Subclinical hypothyroidism quality of life elderly 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Utiger RD. Thyrotropin releasing hormone and thyrotropin secretion. J Lab Clin Med. 1987;109:327–35.PubMedGoogle Scholar
  2. 2.
    Larsen PR. Thyroid-pituitary interaction. Thyroid regulation of thyrotropin secretion by thyroid hormones. N Engl J Med. 1982;306:23–32.PubMedCrossRefGoogle Scholar
  3. 3.
    Evered DC, Ormston BJ, Smith PA, Hall R, Bird T. Grades of hypothyroidism. BMJ. 1973;1:290–3.Google Scholar
  4. 4.
    Cooper DS, Utiger RD, Larsen PR, Ross DS. Subclinical hypothyroidism. Lancet. 1986;251–2. Editorial.Google Scholar
  5. 5.
    Cooper DS. Subclinical hypothyroidism. JAMA. 1987;258:246–7. Editorial.PubMedCrossRefGoogle Scholar
  6. 6.
    Turnbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Wickhan survey. Clin Endocrinol (Oxf). 1977;7:481–93.Google Scholar
  7. 7.
    Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid function in the elderly: microsomal antibodies as discriminant for therapy. JAMA. 1987;258:209–13.PubMedCrossRefGoogle Scholar
  8. 8.
    Pacchiarotti A, Martino E, Bartalena L, et al. Serum free thyroid hormones in subclinical hypothyroidism. J Endocrinol Invest. 1986;9:315–9.PubMedGoogle Scholar
  9. 9.
    Ferrara C, Paracchi E, Parisio E, et al. Serum free thyroid hormones in different degrees of hypothyroidism and in euthyroid autoimmune thyroiditis. Acta Endocrinol (Copenh). 1987;114:559–64.Google Scholar
  10. 10.
    Bell GM, Todd WTA, Forfar JC, et al. End-organ responses to thyroxine in subclinical hypothyroidism. Clin Endocrinol (Oxf). 1985;22:83–9.Google Scholar
  11. 11.
    Forfar JC, Wathem CG, Todd WT, et al. Left ventricular performance in subclinical hypothyroidism. QJM. 1985;57:857–65.PubMedGoogle Scholar
  12. 12.
    Cooper DS, Halpem R, Wood LC, Levin AA, Ridgway EC. L-Thyroxine therapy in subclinical hypothyroidism. A double blind, placebo controlled trial. Ann Intern Med. 1984;101:18–24.PubMedGoogle Scholar
  13. 13.
    Ridgway EC, Cooper DS, Walker H, Rodbard D, Haloof F. Peripheral responses to thyroid hormone before and after L-thyroxine therapy in patients with subclinical hypothyroidism. J Clin Endocrinol Metab. 1981;53:1238–42.PubMedCrossRefGoogle Scholar
  14. 14.
    Nystrom E, Caidahl K, Fager G, Wikkelso C, Lundberg P-A, Lindstedt G. A double-blind cross-over 12-month study ofl-thyroxine treatment of women with “subclinical” hypothyroidism. Clin Endocrinol. 1988;29:63–76.Google Scholar
  15. 15.
    Campbell AJ. Thyroid disorders in the elderly. Difficulties in diagnosis and treatment. Drugs. 1986;31:455–61.PubMedGoogle Scholar
  16. 16.
    Bansal SK, Sahi SP, Basu SK. Old JM. Hypothyroidism in elderly males—an under diagnosis. Br J Clin Pract. 1986;40:17–8.PubMedGoogle Scholar
  17. 17.
    Bahemuka M, Hodkinson HM. Screening for hypothyroidism in elderly Inpatients. BMJ. 1975;2:601–3.PubMedCrossRefGoogle Scholar
  18. 18.
    Felicetta JV. Thyroid changes with aging: significance and management. Geriatrics. 1987;42:86–8,91–2.PubMedGoogle Scholar
  19. 19.
    Ross DS, Neer RM, Ridgway EC, Daniels GH. Subclinical hyperthyroidism and reduced bone density as a possible result of prolonged suppression of the pituitary-thyroid axis with L-thyroxine. Am J Med. 1987;82:1167–70.PubMedCrossRefGoogle Scholar
  20. 20.
    Coindre JM, David JP, Riviere L, et al. Bone loss in hypothyroidism with hormone replacement. A histomorphometric study. Arch Intern Med. 1986;146:48–53.PubMedCrossRefGoogle Scholar
  21. 21.
    Ross DS. Bone density is not reduced during the short-term administration of levo-thyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study. Am J Med. 1993;95:38–58.CrossRefGoogle Scholar
  22. 22.
    Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH. Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med. 1987;316:764–70.PubMedCrossRefGoogle Scholar
  23. 23.
    Jaeschke R, Guyatt G, Cook D, Harper S, Gerstein HC. Spectrum of quality of life impairment in hypothyroidism. Qual Life Res. 1994;3:323–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Jaeschke R, Stager J, Guyatt G. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407–15.PubMedCrossRefGoogle Scholar
  25. 25.
    Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life instrument. J Clin Epidemiol. 1994;47:81–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Juniper EF, Guyatt GH, Feeny DH, Ferrie PJ, Griffith LE, Townsend M. Measuring quality of life in children with asthma. Qual Life Res. 1996;5:35–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Bergner M, Robbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of health status measure. Med Care. 1981;19:797–805.CrossRefGoogle Scholar
  28. 28.
    Rockey PH, Griep RJ. Behavioral dysfunction in hyperthyroidism. Improvement with treatment. Arch Intern Med. 1980;140:1194–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Lezak MD. Neuropsychological Assessment. 2nd ed. New York, NY: Oxford University Press; 1983.Google Scholar
  30. 30.
    Spreen O, Strauss E. Compendium of Neuropsychological Tests. New York, NY: Oxford University Press; 1991.Google Scholar
  31. 31.
    Molloy DW, Beerschoken DA, Borrie MJ, Crilly RG, Cape RDT. Acute effects of exercise on neuropsychological function in elderly subjects. J Am Geriatr Soc. 1988;36:29–33.PubMedGoogle Scholar
  32. 32.
    Denburg SD, Carbotte RM, Denburg JA. Corticosteroids and neuropsychological functioning in patients with systemic lupus erythematosus. Arthritis Rheum. 1994;97:1311–20.CrossRefGoogle Scholar
  33. 33.
    Webber C. Some factors which influence the evaluation of dual photon measurement of lumbar spine bone mineral mass. J Can Assoc Radiol. 1989;40:87–91.Google Scholar
  34. 34.
    Nottestad SY, Baumel JJ, Kimmel DB, Recker RR, Henney RP. The proportion of trabecular bone in human vertebrae. J Bone Miner Res. 1987;2:221–9.PubMedCrossRefGoogle Scholar

Copyright information

© Blackwell Science, Inc. 1996

Authors and Affiliations

  • Roman Jaeschke
    • 1
    • 4
  • Gordon Guyatt
    • 1
    • 2
  • Hertzel Gerstein
    • 1
  • Christopher Patterson
    • 1
  • William Molloy
    • 1
  • Deborah Cook
    • 1
    • 2
    • 4
  • Sandra Harper
  • Lauren Griffith
    • 2
  • Ramona Carbotte
    • 3
  1. 1.the Department of MedicineMcMaster UniversityCanada
  2. 2.the Department of Clinical Epidemiology and BiostatisticsMcMaster UniversityCanada
  3. 3.the Department of PsychiatryMcMaster UniversityCanada
  4. 4.Department of MedicineSt. Joseph’s HospitalHamiltonCanada

Personalised recommendations